AI-native market entry platform for pharma, biotech, and medtech teams, across 90+ markets including all 50 US states.
The data underneath is the same across 90+ markets. What leads, and how the decision is framed, differs by track.
Conformity routes, reference agency reliance, procurement and local representation, read for a device.
Approval, HTA, reference pricing and formulary access, read for a therapeutic.
Each one rated Ready, Moderate, or Complex, calibrated to your product type and the clearances you already hold. No composite score, no weighted average.
The approval or conformity route your existing clearances open, whether the authority runs a reliance route, and which agencies it treats as reference.
The published clock for the route you qualify for, in the regulator’s own units, or marked as unpublished.
Who actually buys, tender, formulary, hospital group or distributor tier, and what registration or listing status is required.
How price is set and constrained, and the effect of a first accepted price on the markets that price against it.
The representative, agent, sponsor or licensed establishment the market requires, and whether it must exist before the clock starts.
Import duty, customs treatment, and the free-zone question.
Illustrative walkthrough: a Class II device entering Indonesia. Eight tools across three stages, each output feeding the next. Each step names the ones it draws on.
The same six dimensions, published on SSRN. Example shown for illustration; every live brief runs on your product and markets.
Map the landscape. A single-market read on Indonesia, then benchmarked against the Philippines and Vietnam across the six dimensions that decide entry.
Whether you have a specific market question, want to book a call, or are interested in a subscription, drop us a message.
30 minutes. We'll walk you through the platform and answer any questions about your specific markets and product type.